User login
Live from the 2013 San Antonio Breast Cancer Symposium, our onsite reporters checked in with meeting attendees to find out the "most interesting thing" they had learned so far. From identifying predictive signatures via genomic data to treating postmenopausal women with bisphosphonates, passing oncologists shared their favorite, potentially practice-changing highlights.
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
Live from the 2013 San Antonio Breast Cancer Symposium, our onsite reporters checked in with meeting attendees to find out the "most interesting thing" they had learned so far. From identifying predictive signatures via genomic data to treating postmenopausal women with bisphosphonates, passing oncologists shared their favorite, potentially practice-changing highlights.
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
Live from the 2013 San Antonio Breast Cancer Symposium, our onsite reporters checked in with meeting attendees to find out the "most interesting thing" they had learned so far. From identifying predictive signatures via genomic data to treating postmenopausal women with bisphosphonates, passing oncologists shared their favorite, potentially practice-changing highlights.